Amgen KRAS blocker shows small improvement in colon cancer response

Amgen KRAS blocker shows small improvement in colon cancer response

STAT Plus: Amgen’s KRAS-blocking drug shows small improvement in colon cancer response

By ADAM FEUERSTEIN

ANNIE CAVANAGH/WELLCOME

Amgen’s experimental KRAS-blocking drug is showing a modest improvement in response rates for patients with advanced colon cancer and other solid tumors.

READ MORE